Results 1 to 10 of about 4,170 (202)

A prospective, multicenter analysis of the integrated 31-gene expression profile test for sentinel lymph node biopsy (i31-GEP for SLNB) test demonstrates reduced number of unnecessary SLNBs in patients with cutaneous melanoma [PDF]

open access: yesWorld Journal of Surgical Oncology
Background National Comprehensive Cancer Network guidelines recommend sentinel lymph node biopsy (SLNB) for patients with > 10% risk of positivity, consider SLNB with 5–10% risk, and foregoing with
Brian Martin   +2 more
exaly   +5 more sources

The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14–I31) is dispensable for the virus in vitro

open access: yesJournal of General Virology, 2004
The human immunodeficiency virus type 1 p6 region encodes p6Gagand the transframe p6Polprotein. The Gag frame encodes an N-terminal late assembly L domain and a C-terminal Vpr binding domain. In the Pol frame, substitution at a C-terminal motif decreases protease autocleavage.
Bleiber G   +5 more
openaire   +4 more sources

CONTROLE IN VITRO DE LARVAS INFECTANTES DE CIATOSTOMÍNEOS (NEMATODA: CYATHOSTOMINAE) DE EQUINOS UTILIZANDO OS FUNGOS PREDADORES Duddingtonia flagrans, Monacrosporium thaumasium e Arthrobotrys robusta

open access: yesCiência Animal Brasileira, 2009
A capacidade predatória de três isolados de fungos predadores de nematoides Duddingtonia flagrans (AC001), Monacrosporium thaumasium (NF34) e Arthrobotrys robusta (I31) sobre larvas infectantes de ciatostomíneos foi avaliada em condições laboratoriais em
Fabio Ribeiro Braga   +5 more
doaj   +3 more sources

Integrating the melanoma 31-gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort [PDF]

open access: yesWorld Journal of Surgical Oncology
Introduction Up to 88% of sentinel lymph node biopsies (SLNBs) are negative. The 31-gene expression profile (31-GEP) test can help identify patients with a low risk of SLN metastasis who can safely forego SLNB.
Chase Kriza   +3 more
doaj   +2 more sources

I31 Deformation Analysis of Periodontium by Using Digital Image Correlation Method

open access: yesThe Proceedings of Conference of Kyushu Branch, 2007
Yasuyuki Morita   +2 more
exaly   +3 more sources

I31 Effects of Mixing Ratio on Diesel Combustion of Palm Oil Methyl Ester with 1-Butanol

open access: yesThe Proceedings of Conference of Kyushu Branch, 2009
Seiji TAKATA   +2 more
exaly   +3 more sources

Flawed Benchmarks and Biased Cohorts: Reassessing the Evidence for CP-GEP (Merlin) Versus 31-GEP (DecisionDx-Melanoma). [PDF]

open access: yesInt J Dermatol
International Journal of Dermatology, Volume 65, Issue 1, Page 12-14, January 2026.
Bellomo D   +5 more
europepmc   +2 more sources

I31 Study on spray behavior of diesel fuel under high ambient pressure condition by using L2F

open access: yesThe Proceedings of Conference of Kyushu Branch, 2011
Keisuke Komada, Hironobu Ueki
exaly   +3 more sources

I31 Visual Observation of the Flow Patterns in a Two-phase Inclined Double-tube Thermosiphon

open access: yesThe Proceedings of Conference of Kyushu Branch, 2008
Masamichi YOSHIDA, Yuuki KITAHARA
exaly   +3 more sources

The integrated 31-gene expression profile (i31-GEP) test for cutaneous melanoma outperforms CP-GEP at identifying patients who can safely forego sentinel lymph node biopsy

open access: yesSKIN The Journal of Cutaneous Medicine, 2022
Introduction: National guidelines for cutaneous melanoma suggest avoiding sentinel lymph node biopsy (SLNB) if the risk of SLN positivity is <5% (T1a with no high-risk features), considering SLNB if the risk is 5-10% (T1a with additional high-risk features (T1aHR) and T1b), and offering SLNB if the risk is >10% (T2-T4). Because most patients (88%)
Abel Jarell, Brian Martin, Peter Prieto
openaire   +2 more sources

Home - About - Disclaimer - Privacy